GoodMind Therapeutics

GoodMind is a South African-based wellness and biotechnology company focused on the therapeutic potential of functional mushrooms and psychedelic-adjacent compounds. Launched as a joint venture between the cannabis company Goodleaf and the investment firm Southern African Cannabis Holdings, the company currently commercializes a range of functional mushroom supplements containing Lion's Mane, Cordyceps, and Reishi. Beyond its current nutraceutical offerings, GoodMind is positioned to explore the emerging psychedelic medicine market, specifically targeting mental health conditions such as anxiety and depression. The company aims to bridge the gap between traditional wellness products and pharmaceutical-grade psychedelic therapies as regulatory frameworks evolve.